Classifications

• • A—HUMAN NECESSITIES
  • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
  • A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
  • A23J3/00—Working-up of proteins for foodstuffs
  • A23J3/30—Working-up of proteins for foodstuffs by hydrolysis
  • A23J3/32—Working-up of proteins for foodstuffs by hydrolysis using chemical agents
  • A23J3/34—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes
• • A—HUMAN NECESSITIES
  • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
  • A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
  • A23G1/00—Cocoa; Cocoa products, e.g. chocolate; Substitutes therefor
  • A23G1/30—Cocoa products, e.g. chocolate; Substitutes therefor
  • A23G1/56—Liquid products; Solid products in the form of powders, flakes or granules for making liquid products, e.g. for making chocolate milk, drinks and the products for their preparation, pastes for spreading or milk crumb
• • A—HUMAN NECESSITIES
  • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
  • A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
  • A23J3/00—Working-up of proteins for foodstuffs
  • A23J3/30—Working-up of proteins for foodstuffs by hydrolysis
  • A23J3/32—Working-up of proteins for foodstuffs by hydrolysis using chemical agents
  • A23J3/34—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes
  • A23J3/341—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes of animal proteins
• • A—HUMAN NECESSITIES
  • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
  • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
  • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
  • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
  • A23L33/16—Inorganic salts, minerals or trace elements
  • A23L33/165—Complexes or chelates
• • A—HUMAN NECESSITIES
  • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
  • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
  • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Definitions

• This invention relates to an iron fortification system which is based upon hydrolysates of egg white protein and which may be used in foods and beverages.
• the invention also relates to a method of preparing the system and to fortifying foods and beverages with iron.
• Iron is an essential trace element in animal and human nutrition. It is a component of heme in hemoglobin and of myoglobin, cytochromes and several enzymes. The main role of iron is its participation in the transport, storage and utilization of oxygen. Inadequate iron is a direct cause of the high incidence of anemia, especially among children, adolescents and women. The need for adequate iron is one which extends for the entire life of the human being.
• iron deficiency is essentially a nutritional problem; a nutritional problem which is common not only in the developing countries. The problem is readily dealt with by consuming foods which naturally provide adequate iron but this is not always possible in disadvantaged societies. Also, many foods normally consumed in developed countries are poor in iron.
• iron To provide a source of iron, many foods and beverages are supplemented with iron.
• the iron source used in supplementation is a soluble iron salt such as ferrous sulfate, ferrous lactate, ferrous gluconate, ferrous fumarate, ferric citrate, ferric choline citrate, and ferric ammonim citrate.
• Ferrous sulfate is especially common due to its good bioavailability.
• iron supplementation and especially ferrous sulfate supplementation has deleterious effects.
• the iron often causes discoloration and off-flavors due to its capacity to interact with polyphenols and lipids and to promote destructive free-
• a soluble iron source for example, the addition of a soluble iron source to chocolate milk powder causes the beverage to turn to dark gray when reconstituted with water or milk. It is believed that this is due to the interaction between the iron and iron sensitive ingredients, such as polyphenols.
• the pH of some iron salts systems may not be compatible with other ingredients or may affect the flavor.
• soluble iron salts can cause corrosion of processing equipment.
• This complex is an iron albumin preparation.
• the albumin is in intact but heat coagulated form.
• the complex is recovered as a precipitate.
• discoloration and oxidation does occur.
• chocolate beverages fortified with iron albumin complexes turn a gray color. More recent examples of iron complexes are described in US patent
• iron complexes are described in US patent 4,172,072 where iron is complexed with substantially completely hydrolyzed collagen.
• Various other completely hydrolyzed proteins are also mentioned as possible ligands.
• the complexes are stated to be stable under acidic conditions and, since the conditions in the gut are acidic, the iron in the complexes is unlikely to have acceptable bioavailability. Also, the complexes are not sufficiently strong to prevent discoloration and lipid oxidation.
• this invention provides an iron-protein hydrolysate complex which comprises ferrous ions chelated to partially hydrolyzed egg white protein having a molecular weight in the range of about 500 to about 10O00.
• complexes formed from iron in the ferrous form and partially hydrolyzed egg white protein are very stable.
• the complexes are sufficiently stable as to be suitable for use in retorted products which contain lipids and polyphenols.
• the iron in the complexes has substantially the same bioavailability as ferrous sulfate; which is remarkably good.
• the partially hydrolyzed egg white protein has a molecular weight in the range of about 2 * 000 to about 6O00.
• this invention provides an iron-protein hydrolysate complex which comprises ferrous ions chelated to egg white protein which is partially hydrolyzed using a microbial protease.
• the microbial protease is a fungal protease obtained from Aspergillus oryzae and contains both endo-peptidase and exo-peptidase.
• this invention provides an iron-protein hydrolysate complex which comprises ferrous ions chelated to partially hydrolyzed egg white protein; the complex containing about 1% to about 2% or about 4.5% to about 10% by dried weight of ferrous ions.
• the complexes are preferably stable at neutral pH but disassociate at a pH below about 3.
• this invention provides a sterilized liquid beverage which contains lipid and a stable iron fortification system, the iron fortification system comprising an iron-protein hydrolysate complex of ferrous ions chelated to partially hydrolyzed egg white protein.
• the beverage may be a chocolate containing beverage.
• this invention provides a sterilized liquid beverage which contains polyphenols and a stable iron fortification system, the iron fortification system comprising an iron-protein hydrolysate complex of ferrous ions chelated to partially hydrolyzed egg white protein.
• the beverage may be a tea beverage.
• the beverages may be sterilized by retorting or ulta high temperature pasteurization.
• the invention also provides a beverage powder which contains lipid and a stable iron fortification system, the iron fortification system comprising an iron- protein hydrolysate complex of ferrous ions chelated to partially hydrolyzed egg white protein.
• the beverage powder may contains chocolate.
• this invention provides a process for preparing an iron fortification system, the process comprising: enzymatically hydrolyzing, preferably under acidic conditions, an egg white protein using a microbial, preferably an acidic fungal, protease to provide a partially hydrolyzed egg white protein; adding a ferrous source to the partially hydrolyzed egg white protein under acidic conditions; and raising the pH to 6.5 to 7.5 for forming a ferrous-hydrolyzed egg white protein complex as the iron fortification system.
• a microbial preferably an acidic fungal, protease
• the partially hydrolyzed egg white protein may be subjected to further hydrolysis steps prior to the addition of the ferrous source.
• the fungal protease is obtained from Aspergillus oryzae and contains both endo-peptidase and exo-peptidase.
• the process may also include the further step of drying the ferrous- hydrolyzed egg white protein complex to a powder form.
• Embodiments of the invention are now described by way of example only.
• This invention is based upon the discovery that partially hydrolyzed egg white protein is able to strongly complex with ferrous ions and yet provide the iron in a bioavailable form.
• the resulting iron complexes have reduced ability to cause deleterious effects such as lipid oxidation, color degradation, and vitamin C degradation. This makes the iron complexes an ideal vehicle for fortifying foods and beverages; especially foods and beverages intended to improve nutritional status.
• the iron source that may be used in the iron complexes may be any food grade ferrous salt, such as ferrous sulfate, ferrous chloride, ferrous nitrate, ferrous citrate, ferrous lactate, or ferrous fumarate, or mixtures thereof.
• the preferred iron source is ferrous sulfate.
• the iron source is preferably provided in the form of a ferrous solution.
• the iron complexes are prepared by preparing partially hydrolyzed egg white protein, adding the iron source under acidic conditions, and then neutralizing. -O-
• the partially hydrolyzed egg white protein should be such that the molecular weight of the protein fractions is in the range of about 500 to about 10000; preferably about 2000 to about 6000. It is found that iron complexes which are prepared from intact egg white protein or extensively hydrolyzed egg white protein are not sufficiently strong. However, iron complexes prepared from partially hydrolyzed egg white protein are extremely stable.
• the hydrolysis of the egg white protein may be carried out in one or more steps as is conventional. However, best results are obtained when the hydrolysis procedure includes an enzymatic hydrolysis step using an acid protease in an acidic medium.
• Suitable acid proteases are commercially available. Particularly suitable acid proteases may be obtained by the controlled fermentation of fungae such as Aspergillus or ⁇ zae. These proteases contain both endo-peptidases and exo-peptidases.
• An example of such an acid enzyme is VALID ASE FP-60 (obtainable from Valley Research, Inc., South Bend, Indiana).
• the medium may be acidified by using a suitable food grade inorganic or an organic grade acid.
• acids which may be used are phosphoric, hydrochloric, sulfuric, lactic, malic, fumaric, gluconic, succinic, ascorbic, or citric.
• the most preferred acid is phosphoric acid.
• the pH may be selected to provide for optimum performance of the enzyme. The pH selected may be that at which the enzyme performs optimally. This information may be obtained from the supplier or by simple trial.
• the hydrolyzed protein obtained after hydrolysis with the acid protease may be used in this form. However, the hydrolyzed protein may be further hydrolyzed if desired.
• any suitable enzyme may be used. Examples include but are not limited to ALCALASE, FLAVORZYME and NEUTRASE, (Novo Nordisk A/S, Novo Alle, Denmark), and PROZYME and PANCREATIN (Amano International Enzyme Co., Inc., Troy, VA).
• the enzymes may be acidic proteases, alkaline proteases or neutral proteases. Particularly suitable are alkaline proteases.
• the partially hydrolyzed egg white protein Prior to adding the iron source to the partially hydrolyzed egg white protein, the partially hydrolyzed egg white protein should be at an acidic pH of about 3.0 to about 5.5. If necessary, the pH may be adjusted by adding a suitable food grade inorganic or an organic grade acid as defined above. The most preferred acid is phosphoric acid.
• the ferrous solution and the partially hydrolyzed egg white protein are then combined. This is preferably carried out under agitation with the ferrous solution added to the partially hydrolyzed egg white protein; preferably slowly.
• the amount of the ferrous solution which is added may be selected to provide the desired ferrous loading.
• the binding of the ferrous in the complex is related to the amount of ferrous bound. Optimum binding is obtained when the complex contains about 1% to about 2% or about 4.5% to about 10% by dried weight of iron. Of course, ferrous loads of more than 10% may be used but the binding, and hence the stability of the complex, may be slightly less.
• the solution After adding the iron source to the partially hydrolyzed egg white protein, the solution should be neutralized to promote the formation of a ferrous complex. However, the mixture should not be allowed to become basic to avoid precipitation and the formation of hydroxide ions. A pH in the range of about 6.5 to about 7.5 is recommended.
• an alkali may be added to neutralize the pH of the mixture.
• Any food grade alkali may be used for neutralization, including but not limited to sodium hydroxide, potassium hydroxide, ammonia hydroxide, magnesium hydroxide, sodium carbonate, sodium bicarbonate, potassium carbonate, and potassium bicarbonate. Ammonia hydroxide is preferred. All steps are preferably carried out under agitation.
• the complexes obtained may be used in liquid form as obtained. More preferably however, the complexes are dried to powder. The drying may be freeze drying or may be spray drying. Any suitable procedure for spray- or freeze-drying the complexes to powder may be used. Suitable procedures are known in the art.
• the complexes are included in the ingredients making up the desired foods or beverage and the ingredients processed in the normal way.
• bioavailability of the iron may be slightly less than that of ferrous sulfate, it is found that it is well within acceptable limits. In most cases, the statistical difference in bioavailability is not significant. Further, it is found that the complexes are very stable and when used in foods and beverages, do not lead to increased discoloration or off-flavor generation. Moreover, it is found that the complexes do not increase processing problems such as fouling.
• the complexes are particularly suitable for use in foods or beverages in liquid form; for example infant formula concentrates and ready-to-drink beverages such as chocolate and malted milk drinks. These foods or beverages usually undergo retorting or other sterilization as part of their processing and hence the ability of the complexes to withstand harsh treatment provides a great improvement.
• the complexes may be used in other types of foods or beverages such as powdered beverages, infant formulas, and infant cereals.
• the complexes may also be included in pet foods which usually contain lipids and vitamins.
• Products which contain the complexes are perceived to have similar organoleptic properties and color as compared to unfortified products. This offers the advantage that products may be fortified without causing noticeable changes which may adversely affect consumer perception. Also, it is found that vitamin C is not degraded by the complexes. Hence the complexes may be used in products which are intended to be nutritionally balanced.
• An amount of 1000 g of frozen egg white is added to a fermentor (Biostat ® M) and allowed to thaw at room temperature. The pH is slowly adjusted to 3.0 using 85% H 3 P0 under agitation. The solution is then heated to 42 °C. An amount of 2.5 g of an acid protease (VALIDASE FP60 obtained from Valley Research, Inc or South Bend, Indiana) is added and the solution allowed to react for 16 hours under low/medium agitation at a pH of 3.0 to 3.3. This acid protease is obtained from Aspergillus oryzae and contains both endo-peptidase and exo-peptidase. After 16 hours of reaction, ammonium hydroxide (28%) is added to raise the pH to 7.4.
• VALIDASE FP60 obtained from Valley Research, Inc or South Bend, Indiana
• alkaline protease (ALCALASE 2.4L, obtained from Novo Nordisk A7S) is added and the temperature of the solution is raised to 50 °C under agitation.
• This protease is obtained from a strain of Bacillus licheniformis and contains mainly endo-proteinase.
• the solution is cooled to room temperature.
• An amount of 43.5 g of 85% H 3 P0 4 is added followed by an amount of 5.0 g of FeS0 .7H 2 0 in 50 ml of H 2 0, both under agitation.
• the pH is then adjusted to 6.7 with 28% NH OH under agitation.
• the solution is then heated to a temperature of 90 °C for 10 minutes.
• the solution is then cooled to room temperature.
• Example 2 The liquid iron complex is collected.
• Example 2 The liquid iron complex is collected.
• the powdered iron complex is collected.
• the solution is cooled to room temperature.
• An amount of 5.0 g of FeS0 .7H 2 0 in 50 ml of H 2 0 is added under agitation.
• the pH is then adjusted to 6.7 with 28% NH 4 OH under agitation.
• the solution is then heated to a temperature of 60 °C for 10 minutes.
• the solution is then cooled to room temperature.
• example 1 The process of example 1 is repeated except that the egg white is subjected to hydrolysis for 6 hours. The powdered iron complex is collected.
• chocolate milk beverages are prepared by reconstituting a chocolate milk powder (QUIK, Nestle USA, Inc) to a concentration of 8.5% by weight.
• Each beverage contains 12.5 ppm of added iron in the form of a different iron complex of one of examples 1 to 4.
• the beverages are placed into sealed 125 ml glass jars and autoclaved at about 121°C (250°F) for 5 minutes.
• the jars are cooled to room temperature and stored for 6 months.
• the beverages are evaluated for physical stability, color and taste after 1, 2, 3, 4, 5 and 6 months. Taste is judged by a taste panel of 10 people. All beverages are judged to be without discoloration, sedimentation or coagulation and of a good flavor.
• chocolate milk beverages are prepared by reconstituting a chocolate milk powder (QUIK, Nestle USA, Inc) to a concentration of 8.5% by weight.
• Each beverage contains 12.5 ppm of added iron in the form of a different iron complex of one of examples 1 to 4.
• the beverages are pre-heated to about 80°C (175°F), heated to about 140°C (285°F) by steam injection, held at this temperature for 5 seconds, and cooled to about 80°C (175°F).
• the beverages are then homogenized at about 17/3.5 MPa (2500/500 psi), cooled to about 16°C (60°F) and filled in 250 ml
• Tetra Brik Aseptic® packages (Terra Pak Inc., Chicago IL).
• the beverages are evaluated for physical stability, color and taste after 1 day, 2 weeks, and 1 and 2 months. Taste is judged by a taste panel of 10 people. All beverages are judged to be without discoloration, sedimentation or coagulation and of a good flavor.
• chocolate milk beverages are prepared by reconstituting a chocolate milk powder (QUIK, Nestle USA, Inc) to a concentration of 8.5% by weight.
• Each beverage contains 12.5 ppm of added iron in the form of a different iron complex of one of examples 1 to 4.
• the beverages are pre-heated to about 80°C (175°F), heated to about 148°C (298°F) by steam injection, held at this temperature for 5 seconds, and cooled to about 80°C (175°F).
• the beverages are then homogenized at about 17/3.5 MPa (2500/500 psi), cooled to about 16°C (60°F) and filled in 250 ml Terra Brik Aseptic® packages (Terra Pak Inc., Chicago IL).
• the beverages are evaluated for physical stability, color and taste after 1, 2, 3, 4, 5 and 6 months. Taste is judged by a taste panel of 10 people. All beverages are judged to be without discoloration, sedimentation or coagulation and of a good flavor.
• Each beverage comprises 22.0 g of powder in 180 ml of boiling water.
• An iron complex of each of examples 2 to 4 is added to both a chocolate beverage and a malted beverage.
• the final iron concentrations in the chocolate beverages are 15.0 ppm and in the malted beverages are 25.0 ppm.
• the beverage are stirred briefly and allowed to stand for 15 minutes at room temperature. After 15 minutes, beverages are judged by a taste panel of 10 people. No color change or off flavors are found when samples are compared to control samples without added iron.
• Three infant cereal meals are prepared by reconstituting 55 g of banana containing infant cereal (Nestle USA, Inc) with 180 ml of boiling water. Iron complexes of examples 2 to 4 added to each cereal to provide 7.5 mg of iron per 100 g of cereal powder.
• Each cereal meal is stirred briefly and allowed to stand for 15 minutes at room temperature. After 15 minutes, the cereal meals are judged by a taste panel of 10 people. No color change or off flavors are found when samples are compared to control samples without added iron.
• the bioavailabilities of the complexes are determined as follows :- Animals:- The animals used are weanling male Sprague-Dawley rats aged 3 weeks (IFFA-CREDO, L'Arbresle, France).
• the control diet is an ICN Low-Iron diet (Soccochim SA, Lausanne, Switzerland) which has an iron content of 3 mg/kg. This diet is casein based and provides for the nutritional requirements of growing rats except for iron.
• the experimental diets are:- Diet A:- The control diet supplemented with FeS0 .7H 2 0 to provide 10 mg/kg iron.
• Diet B The control diet supplemented with FeS0 4 .7H 2 0 to provide 20 mg/kg iron.
• Diet 1 The control diet supplemented with the complex of example 4 to provide 10 mg/kg iron.
• Diet 2 The control diet supplemented with the complex of example 4 to provide 20 mg/kg iron.
• Diet 3 The control diet supplemented with 10 mg/kg of the complex of example 2 to provide 10 mg/kg iron.
• Diet 4 The control diet supplemented with 20 mg/kg of the complex of example 2 to provide 20 mg/kg iron.
• Hemoglobin analysis is performed by anaesthetizing the rats with isoflurane and then drawing a sample of 200 ⁇ L of blood from the orbital venous plexus. Blood hemoglobin level in the sample is determined by the cyanmethemoglobin method (Hb kit MPR 3, Boehringer Mannheim GmbH, Germany), using an automated instrument (Hemocue, Baumann-Medical SA, Wetzikon, Switzerland). Commercial quality control blood samples (Dia-HT Kontrollblut, Dia MED, Cressier, Switzerland) having a range of hemoglobin levels are measured with all hemoglobin determinations.
• Fe-bioavailability as compared to ferrous sulfate heptahydrate is evaluated using a slope-ratio calculation based upon hemoglobin levels.
• a multiple regression equation relates amounts of iron added to the hemoglobin levels. The equation provides one straight line per diet which intercepts at zero dose. The bioavailability of the iron source relative to ferrous sulfate heptahydrate is then calculated as the ratio of the two slopes. The ratio is multiplied by 100 to provide the relative bioavailability value.
• Rats are housed individually in polycarbonate cages, fitted with stainless steel grids. The animals are allowed free access to distilled water. To render the rats anemic, the rats have ad libitum access to the control diet for 24 days. Fresh diet is supplied daily. Spoiling of diet by rats is reduced by covering the diet with a grid.
• hemoglobin and weight is determined. Seventy rats with hemoglobin levels between 4.5 and 5.8 mg/dl are randomized into 7 groups of 10 having approximately equal mean hemoglobin and body weight. Each group of animals is fed one of the experimental diets for 14 days. The rats are fed the diets ad libitum beginning with 20 g/day at day 0. The rats have free access to distilled water. Individual food consumption is measured daily. After 14 days, the rats are weighed and hemoglobin is determined.
• Mean food consumption and iron intake is not affected by the type of iron source.
• the rats receiving no added iron ate less than those receiving iron.
• the rats consuming diets with 20 mg/kg of added iron consume slightly more than those receiving diets with 10 mg/kg iron. Weight increase of the rats is not affected by the type of iron source.
• the rats receiving no added iron gained less weight than those receiving iron.
• the rats receiving diets with 20 mg/kg iron gain slightly more weight than those receiving the diets with 10 mg/kg iron.
• the relative bioavailabilities are as follows:-
• the bioavailabilities of all of the Fe-protein complexes are similar to that of ferrous sulfate.
• a relative bioavailability value of less than 91% is taken to be significantly less than the reference. Therefore, from a statistical point of view, the relative bioavailability values of the iron complexes of example 2 are similar to that of ferrous sulfate. However, from a practical viewpoint, all of the complexes have very good bioavailability.

Landscapes

• Chemical & Material Sciences (AREA)
• Life Sciences & Earth Sciences (AREA)
• Engineering & Computer Science (AREA)
• Food Science & Technology (AREA)
• Polymers & Plastics (AREA)
• Health & Medical Sciences (AREA)
• Nutrition Science (AREA)
• Chemical Kinetics & Catalysis (AREA)
• General Chemical & Material Sciences (AREA)
• Biochemistry (AREA)
• Zoology (AREA)
• Inorganic Chemistry (AREA)
• Mycology (AREA)
• Coloring Foods And Improving Nutritive Qualities (AREA)
• Superconductors And Manufacturing Methods Therefor (AREA)
• Iron Core Of Rotating Electric Machines (AREA)
• Load-Engaging Elements For Cranes (AREA)
• Peptides Or Proteins (AREA)
• Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
• Preparation Of Compounds By Using Micro-Organisms (AREA)
• Percussion Or Vibration Massage (AREA)
• Confectionery (AREA)
• Tea And Coffee (AREA)
• Non-Alcoholic Beverages (AREA)
• Hard Magnetic Materials (AREA)
• Coating With Molten Metal (AREA)
• Investigating Or Analyzing Materials By The Use Of Magnetic Means (AREA)

Priority Applications (11)

Applications Claiming Priority (2)

Publications (1)

Family

ID=22401818

Family Applications (1)

Country Status (20)

Cited By (7)

Families Citing this family (10)

Citations (9)

• 2000
  • 2000-03-01 RU RU2001126394/13A patent/RU2001126394A/ru unknown
  • 2000-03-01 JP JP2000601927A patent/JP2002537787A/ja active Pending
  • 2000-03-01 BR BR0008690-8A patent/BR0008690A/pt not_active Application Discontinuation
  • 2000-03-01 EP EP00910743A patent/EP1156719B1/en not_active Expired - Lifetime
  • 2000-03-01 CN CN00807029A patent/CN1349386A/zh active Pending
  • 2000-03-01 IL IL14898200A patent/IL148982A0/xx unknown
  • 2000-03-01 HU HU0200175A patent/HUP0200175A2/hu unknown
  • 2000-03-01 AU AU32846/00A patent/AU3284600A/en not_active Abandoned
  • 2000-03-01 NZ NZ514063A patent/NZ514063A/xx not_active Application Discontinuation
  • 2000-03-01 PL PL00350281A patent/PL350281A1/xx unknown
  • 2000-03-01 CA CA002392586A patent/CA2392586A1/en not_active Abandoned
  • 2000-03-01 AT AT00910743T patent/ATE240052T1/de not_active IP Right Cessation
  • 2000-03-01 KR KR1020017011129A patent/KR20010108291A/ko not_active Withdrawn
  • 2000-03-01 WO PCT/EP2000/001743 patent/WO2000051447A1/en not_active Ceased
  • 2000-03-01 ID IDW00200102092A patent/ID30490A/id unknown
  • 2000-03-01 DE DE60002678T patent/DE60002678T2/de not_active Expired - Fee Related
  • 2000-03-01 TR TR2001/02536T patent/TR200102536T2/xx unknown
  • 2000-03-01 ES ES00910743T patent/ES2199143T3/es not_active Expired - Lifetime
• 2001
  • 2001-08-24 NO NO20014129A patent/NO20014129L/no unknown
  • 2001-08-27 ZA ZA200107082A patent/ZA200107082B/xx unknown

Patent Citations (9)

Non-Patent Citations (2)

Also Published As

Similar Documents

Legal Events